{"id":"https://openalex.org/W7093549758","doi":null,"title":"Evaluation of the intracellular signaling activities of \u03ba opioid receptor agonists, nalfurafine analogs; focusing on the selectivity of G protein- and \u03b2-arrestin-mediated pathways","display_name":"Evaluation of the intracellular signaling activities of \u03ba opioid receptor agonists, nalfurafine analogs; focusing on the selectivity of G protein- and \u03b2-arrestin-mediated pathways","alternate_titles":[],"publication_year":2023,"publication_date":"2023-03-20","ids":{"openalex":"https://openalex.org/W7093549758"},"language":"en","primary_location":{"id":"pmh:oai:jair.repo.nii.ac.jp:02003003","doi":null,"is_oa":true,"landing_page_url":"https://jair.repo.nii.ac.jp/records/2003003","pdf_url":"https://jair.repo.nii.ac.jp/record/2003003/files/MDK2688-zenbunpu.pdf","source":null,"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"VoR"},"parent_works":[],"lineage":["https://openalex.org/W7093549758"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://jair.repo.nii.ac.jp/record/2003003/files/MDK2688-zenbunpu.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"\u5c71\u53e3, \u653f\u5e83","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"\u5c71\u53e3, \u653f\u5e83","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"\u30e4\u30de\u30b0\u30c1, \u30de\u30b5\u30d2\u30ed","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"\u30e4\u30de\u30b0\u30c1, \u30de\u30b5\u30d2\u30ed","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.5029000043869019,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.5029000043869019,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.48510000109672546,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kappa-opioid-receptor","display_name":"kappa opioid receptor","score":0.8980000019073486},{"id":"https://openalex.org/keywords/nalfurafine","display_name":"nalfurafine","score":0.9229999780654907},{"id":"https://openalex.org/keywords/g-protein-biased-agonists","display_name":"G protein-biased agonists","score":0.7549999952316284},{"id":"https://openalex.org/keywords/beta-arrestin-signaling","display_name":"\u03b2-arrestin signaling","score":0.8730000257492065},{"id":"https://openalex.org/keywords/receptor-selectivity","display_name":"receptor selectivity","score":0.5910000205039978},{"id":"https://openalex.org/keywords/bias-factor","display_name":"bias factor","score":0.6679999828338623},{"id":"https://openalex.org/keywords/opioid-analgesics","display_name":"opioid analgesics","score":0.8619999885559082},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7099999785423279}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7120000123977661},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.5227000117301941},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.47540000081062317},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.45249998569488525},{"id":"https://openalex.org/C2779886867","wikidata":"https://www.wikidata.org/wiki/Q421797","display_name":"Opioid receptor","level":4,"score":0.4440999925136566},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.43860000371932983},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.42809998989105225},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3709000051021576},{"id":"https://openalex.org/C43587935","wikidata":"https://www.wikidata.org/wiki/Q1258877","display_name":"Functional selectivity","level":4,"score":0.3499000072479248},{"id":"https://openalex.org/C118792377","wikidata":"https://www.wikidata.org/wiki/Q108584245","display_name":"Selectivity","level":3,"score":0.3409999907016754},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.271699994802475},{"id":"https://openalex.org/C135285700","wikidata":"https://www.wikidata.org/wiki/Q38173","display_name":"G protein-coupled receptor","level":3,"score":0.2705000042915344},{"id":"https://openalex.org/C117943116","wikidata":"https://www.wikidata.org/wiki/Q1135604","display_name":"Receptor-mediated endocytosis","level":4,"score":0.25999999046325684},{"id":"https://openalex.org/C88016717","wikidata":"https://www.wikidata.org/wiki/Q417189","display_name":"Opioid peptide","level":4,"score":0.258899986743927},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.2587999999523163},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.25099998712539673}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:jair.repo.nii.ac.jp:02003003","doi":null,"is_oa":true,"landing_page_url":"https://jair.repo.nii.ac.jp/records/2003003","pdf_url":"https://jair.repo.nii.ac.jp/record/2003003/files/MDK2688-zenbunpu.pdf","source":null,"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"VoR"},{"id":"pmh:oai:irdb.nii.ac.jp:01305:0006292964","doi":null,"is_oa":true,"landing_page_url":"https://jair.repo.nii.ac.jp/records/2003003","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"doctoral thesis"}],"best_oa_location":{"id":"pmh:oai:jair.repo.nii.ac.jp:02003003","doi":null,"is_oa":true,"landing_page_url":"https://jair.repo.nii.ac.jp/records/2003003","pdf_url":"https://jair.repo.nii.ac.jp/record/2003003/files/MDK2688-zenbunpu.pdf","source":null,"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"VoR"},"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1193904506","display_name":"Establishment of optimal sequential administration of opioids based on the intracellular localization of opioid receptors and its changes in activity","funder_award_id":"21K08924","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G529179488","display_name":"Development of novel mu-opioid receptor-selective opioids with less adverse effects","funder_award_id":"21K06584","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G6767497640","display_name":"Development of novel, specific heterodimerized opioid agonists with less tolerance and side effects","funder_award_id":"18K07404","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7093549758.pdf","grobid_xml":"https://content.openalex.org/works/W7093549758.grobid-xml"},"referenced_works_count":73,"referenced_works":["https://openalex.org/W288529417","https://openalex.org/W781766254","https://openalex.org/W872502237","https://openalex.org/W1608126058","https://openalex.org/W1775629781","https://openalex.org/W1971805652","https://openalex.org/W1976506153","https://openalex.org/W1979013132","https://openalex.org/W1992787959","https://openalex.org/W1997596715","https://openalex.org/W1999561809","https://openalex.org/W2000328742","https://openalex.org/W2001453572","https://openalex.org/W2005643237","https://openalex.org/W2006215870","https://openalex.org/W2008852855","https://openalex.org/W2010158373","https://openalex.org/W2010531200","https://openalex.org/W2010654991","https://openalex.org/W2011645297","https://openalex.org/W2015087988","https://openalex.org/W2016575990","https://openalex.org/W2020850711","https://openalex.org/W2023948580","https://openalex.org/W2024012275","https://openalex.org/W2028772329","https://openalex.org/W2032643119","https://openalex.org/W2036801804","https://openalex.org/W2043184629","https://openalex.org/W2047762719","https://openalex.org/W2050997100","https://openalex.org/W2052191785","https://openalex.org/W2059628641","https://openalex.org/W2061326578","https://openalex.org/W2062106032","https://openalex.org/W2072840386","https://openalex.org/W2080242611","https://openalex.org/W2083248667","https://openalex.org/W2090562839","https://openalex.org/W2101369399","https://openalex.org/W2107153432","https://openalex.org/W2112482916","https://openalex.org/W2116151143","https://openalex.org/W2121473111","https://openalex.org/W2123895632","https://openalex.org/W2136531357","https://openalex.org/W2137154584","https://openalex.org/W2137887442","https://openalex.org/W2140123841","https://openalex.org/W2157458341","https://openalex.org/W2163039776","https://openalex.org/W2211369331","https://openalex.org/W2269501814","https://openalex.org/W2321068107","https://openalex.org/W2557809815","https://openalex.org/W2579679755","https://openalex.org/W2612657724","https://openalex.org/W2618612984","https://openalex.org/W2770319189","https://openalex.org/W2790983564","https://openalex.org/W2792983781","https://openalex.org/W2797932292","https://openalex.org/W2884887849","https://openalex.org/W2902898515","https://openalex.org/W2919143465","https://openalex.org/W2940073658","https://openalex.org/W2954929693","https://openalex.org/W2981537004","https://openalex.org/W3006232652","https://openalex.org/W3084432280","https://openalex.org/W3097205722","https://openalex.org/W3147972486","https://openalex.org/W4223970543"],"related_works":["https://openalex.org/W2579679755","https://openalex.org/W2321068107","https://openalex.org/W3009748748","https://openalex.org/W4225413407","https://openalex.org/W3084432280","https://openalex.org/W2765427553","https://openalex.org/W2940073658","https://openalex.org/W2088682619","https://openalex.org/W2884887849","https://openalex.org/W2725512209"],"abstract_inverted_index":{"Opioid":[0],"receptors":[1],"(ORs)":[2],"are":[3,15,89,100],"classified":[4],"into":[5],"three":[6],"types":[7],"(\u03bc,":[8],"\u03b4,":[9],"and":[10,12,63,114],"\u03ba),":[11],"opioid":[13],"analgesics":[14,71],"mainly":[16,54],"mediated":[17],"by":[18,27],"\u03bcOR":[19],"activation;":[20],"however,":[21,79],"their":[22],"use":[23],"is":[24],"sometimes":[25],"restricted":[26],"unfavorable":[28],"effects.The":[29],"selective":[30],"\u03baOR":[31,70,181],"agonist":[32],"nalfurafine":[33,88,98,113,116,168],"was":[34,43],"initially":[35],"developed":[36],"as":[37,175],"an":[38],"analgesic,":[39],"but":[40],"its":[41],"indication":[42],"changed":[44],"because":[45],"of":[46,52,87,97,105,112,149,158],"the":[47,67,80,85,94,103,110,143,156,159,164],"narrow":[48],"safety":[49],"margin.The":[50],"activation":[51],"ORs":[53],"induces":[55],"two":[56,107],"intracellular":[57],"signaling":[58,151],"pathways:":[59],"a":[60,64,128,171],"G-protein-mediated":[61,150],"pathway":[62],"\u03b2-arrestin-mediated":[65,165],"pathway.Recently,":[66],"expectations":[68],"for":[69,84,102],"that":[72,99],"selectively":[73],"activate":[74],"these":[75,106],"pathways":[76],"have":[77],"increased;":[78],"structural":[81],"properties":[82,111],"required":[83],"selectivity":[86,104,148],"still":[90],"unknown.Therefore,":[91],"we":[92],"evaluated":[93],"partial":[95],"structures":[96],"necessary":[101],"pathways.We":[108],"assayed":[109],"six":[115],"analogs":[117,169],"(SYKs)":[118],"using":[119],"cells":[120],"stably":[121],"expressing":[122],"\u03baORs.The":[123],"SYKs":[124],"activated":[125],"\u03baORs":[126],"in":[127],"concentration-dependent":[129],"manner":[130],"with":[131],"higher":[132,147],"EC50":[133],"values":[134],"than":[135,153],"nalfurafine.Upon":[136],"bias":[137],"factor":[138],"assessment,":[139],"only":[140],"SYK-309":[141],"(possessing":[142],"3S-hydroxy":[144,160,172],"group)":[145],"showed":[146],"activities":[152],"nalfurafine,":[154],"suggesting":[155],"direction":[157],"group":[161],"may":[162],"affect":[163],"pathway.In":[166],"conclusion,":[167],"having":[170],"group,":[173],"such":[174],"SYK-309,":[176],"could":[177],"be":[178],"considered":[179],"G-protein-biased":[180],"agonists.":[182]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7093549758","counts_by_year":[],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2025-10-24T00:00:00"}
